SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-24-022890
Filing Date
2024-02-02
Accepted
2024-02-02 16:32:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G d649448dsc13g.htm SC 13G 50948
  Complete submission text file 0001193125-24-022890.txt   52616
Mailing Address 300 TECHNOLOGY SQUARE 8TH FLOOR CAMBRIDGE MA 02139
Business Address 300 TECHNOLOGY SQUARE 8TH FLOOR CAMBRIDGE MA 02139 857-201-2700
Dianthus Therapeutics, Inc. /DE/ (Subject) CIK: 0001690585 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90538 | Film No.: 24592016
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 200 CLARENDON STREET BOSTON MA 02116
Business Address 200 CLARENDON STREET BOSTON MA 02116 6175162000
BCLS Fund III Investments, LP (Filed by) CIK: 0001952107 (see all company filings)

IRS No.: 873064173 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G